Scientists hope an ingredient found in cannabis could one day be used to treat people addicted to heroin and in turn help tackle the opioid crisis.
Pfizer obtained FDA approval for drugs Vyndaqel and Vyndamax to treat patients with transthyretin amyloid cardiomyopathy. Vyndaqel and Vyndamax are the ...
Intravenous golimumab, in doses of 2 mg per kg, reduced the signs and symptoms of psoriatic arthritis through1 year, with improvements in health-related quality ...
DALLAS — Patients with interstitial lung disease associated with systemic sclerosis treated with the tyrosine kinase inhibitor nintedanib exhibited a 44% ...
Quality-adjusted progression free survival and quality-adjusted time without cancer related symptoms or toxicity demonstrate the benefit of Rubraca ...
OTX-TP failed to meet primary endpoint but achieved statistically significant reduction of intraocular pressure versus placebo at eight of the nine pre-specified ...
Among patients in SINUS-24 and SINUS-52 with chronic rhinosinusitis with nasal polyps and comorbid asthma, dupilumab significantly improved function and ...
The addition of nintedanib (Ofev) to standard of care pemetrexed (Alimta) plus cisplatin failed to delay disease progression in patients with unresectable ...